Home
About Us
Products
Technical Service
News
Contact Us
CN
Company News
Industry News
FDA approves the first new drug for metabolic steatohepatitis (NAS H/M ASH)!
2024-03-18
本文摘自——药精通Bio
The first TCR therapy: it sold for 1.8 billion yuan in 2023, up 43%
2024-03-15
本文摘自——药融圈
Gene therapy: AAV vectors continue to deliver functional genes to patients
2024-03-14
本文摘自——药精通Bio
Vector articles of gene therapy
2024-03-13
本文摘自——药精通Bio
Smesiglutide
2024-03-12
本文摘自——药融圈
In 2024, where are the prospects of innovative drugs?
2024-03-11
本文摘自——药精通Bio
Pre
23
24
25
26
27
28
29
30
Next
30Pages
Consultation with online customer service
Service hotline
025-58906079
18066052887
功能和特性
价格和优惠
获取内部资料